Difference between revisions of "DZI20-210-Case-5"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
Line 11: Line 11:
 
IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-.
 
IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-.
 
|reasonCode=86 yo man with tumor with ulceration for 3 months. (Guitart et al, Mod Path 30:761-72, 2017 , case #20)
 
|reasonCode=86 yo man with tumor with ulceration for 3 months. (Guitart et al, Mod Path 30:761-72, 2017 , case #20)
|subject=public
+
|subject=MGH
|performer=Vn048
+
|performer=VN048
 
|authoredOn=October 21, 2020 02:36:54 PM
 
|authoredOn=October 21, 2020 02:36:54 PM
 
|requester=Vn048
 
|requester=Vn048
 
|sequence=5
 
|sequence=5
 +
|access=public
 
}}
 
}}
 
{{Media
 
{{Media

Revision as of 15:17, June 21, 2022

DZI20-210-Case-5
86 yo man with tumor with ulceration for 3 months. (Guitart et al, Mod Path 30:761-72, 2017 , case #20)
Skin, right flank tumor: CD8+ tumor stage T-cell lymphoma. IHC shows abnormal lymphoid cells are CD3+ CD5 weak/variable, CD8+ CD4- TIA1+ TCR beta+ CD2- CD30- CD25- CD56-.
December 31, 1969 7:00:00 PM